Skip to content
The Korea Update

The Korea Update

All about Korea

  • Plan Your Trip
    • Visa Guide
    • Where to Stay
    • Transport
    • Must-Have Apps
    • Connectivity
    • Money & Banking
    • Emergency & Safety
  • Where to Go
    • Must-Visit Places
    • K-Pop Spots
  • Things to Do
    • Event & Festival
    • Tour
    • Food
    • Shopping
  • Korea Now
    • K-Pop
    • Entertainment
    • Business & Economy
  • Home
  • Korea Now
  • Business & Economy
  • Daewoong Pharma AI Health Monitoring Expansion
  • Business & Economy

Daewoong Pharma AI Health Monitoring Expansion

editor 2월 23, 2026
Daewoong Pharma AI Health Monitoring Expansion

Korean drugmaker aims to deploy smart monitoring system to 100,000 hospital beds by end of 2026

Park Hyung-chul, head of Daewoong Pharmaceutical’s Ethical Drugs, or ETC, Marketing Division, speaks in a press conference at the JW Marriott Hotel Dongdaemun in Seoul on Monday. (Daewoong Pharmaceutical)

Daewoong Pharmaceutical announced plans on Monday to accelerate the implementation of an AI-powered patient monitoring system. This system aims to enhance patient safety by providing round-the-clock monitoring for medical staff in hospitals across Korea.

The company highlighted the launch of thynC, an advanced version of their AI-based smart hospital bed monitoring system. This upgraded platform integrates various patient data sets into a single location, leveraging AI for comprehensive health monitoring.

“The ‘faster, closer, and smarter’ vision, which we outlined last year, is now a reality in clinical settings,” stated Park Hyung-chul, head of Daewoong Pharmaceutical’s Ethical Drugs (ETC) Marketing Division, during a press conference held at the JW Marriott Hotel Dongdaemun in Seoul.

“Digital healthcare has transitioned beyond its initial stages and has become an indispensable technology for companies, healthcare providers, and patients, creating a mutually beneficial environment.”

Daewoong Pharmaceutical is the exclusive distributor of thynC in Korea, collaborating with Seers Technology, the developer of the system, which was commercialized in February 2024. Daewoong is also a strategic investor in Seers Technology, which went public on the KOSDAQ in June 2024.

As of February 9th, thynC has been installed on approximately 15,000 hospital beds in 162 hospitals nationwide, according to Daewoong Pharmaceutical. The company aims to expand its reach to 100,000 beds by the end of 2026.

Daewoong Pharmaceutical’s digital healthcare business segment reported 50.9 billion won in sales last year, a 123 percent increase from 2024. The company has set a target of achieving 300 billion won in annual revenue.

The enhanced thynC incorporates new functionalities from collaborations with three different companies: SkyLab’s ring-type device for blood pressure tracking, iKooB’s glucose monitoring system, and Puzzle AI’s voice-recognition note-taking solution for automated logging of medical information spoken by doctors and nurses.

The original thynC version features wearable biosensors, such as a watch, to monitor vital signs including electrocardiogram, oxygen saturation, heart rate, respiration rate, and body temperature. The system alerts medical staff in the event of any anomalies.

“Our ultimate vision is to establish a continuous 24-hour health monitoring system extending to patients’ homes, enabling ongoing health condition checks even after discharge from the hospital,” Park concluded.

hwkan

Klook.com
Tags: Daewoong Expansion Health Korean business Korean economy Monitoring Pharma

Post navigation

Previous K-Pop Domination: IFPI Global Album Chart Top 10
Next Blackpink YouTube 100 Million Subscribers Milestone

Related Stories

SK Group Chairman’s 1.4 Trillion Won Divorce Settlement Enters Court Mediation SK Group Chairman's 1.4 Trillion Won Divorce Settlement Enters Court Mediation
  • Business & Economy

SK Group Chairman’s 1.4 Trillion Won Divorce Settlement Enters Court Mediation

4월 17, 2026
Hanwha Solutions Reduces Rights Offering Amid Regulator Scrutiny, Shareholder Backlash Hanwha Solutions Reduces Rights Offering Amid Regulator Scrutiny, Shareholder Backlash
  • Business & Economy

Hanwha Solutions Reduces Rights Offering Amid Regulator Scrutiny, Shareholder Backlash

4월 17, 2026
KIT World Seals US Investor Project Deal KIT World Seals US Investor Project Deal
  • Business & Economy

KIT World Seals US Investor Project Deal

4월 17, 2026

Exchange Rate

Exchange Rate KRW: 금, 17 4월.

Seoul
Current weather
-º
Sunrise-
Sunset-
Humidity-
Wind direction-
Pressure-
Cloudiness-
-
-
Forecast
Rain chance-
-
-
Forecast
Rain chance-
-
-
Forecast
Rain chance-
-
-
Forecast
Rain chance-
Seoul weather
  • About Us
  • Privacy Policy
  • Contact
Copyright © All rights reserved. | DarkNews by AF themes.